Skip to main content
Pay Bill Portals

Leveraging Signatera Residual Disease Test (MRD) to Support More Patients Who Can Benefit from Hereditary Cancer Testing

Published Date

New Hereditary Cancer Alert Program (HCAP) Pilot Increase Patients Tested by 200%